Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Therapeutics Area; By Workflow; By Region; Segment Forecast, 2022 - 2030

Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Therapeutics Area; By Workflow; By Region; Segment Forecast, 2022 - 2030

The global clinical trials outsourcing market size is expected to reach USD 67.62 billion by 2030, according to a new study by Polaris Market Research. The report “Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others); By Therapeutics Area; By Workflow; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical and biotechnology businesses outsource clinical trials because they lack the requisite resources, experience, and time. Clinical trial outsourcing includes advantages such as lower costs, shorter turnaround times, and better results. Most clinical trials are contracted out to suppliers and contract research organisations.

The active pharmaceutical ingredients are used to create dosage forms, which are often created remotely from the locations where tablets, suspensions, and liquids are formed. As a result, more companies are outsourcing the manufacturing of API to countries with affordable labour. These factors contribute to the market need for clinical trials outsourcing on a global scale.

In the past decade, multinational pharmaceutical businesses have successfully established a variety of sourcing methods and service lines in emerging markets, either through local affiliates or service providers. Although these regions were originally given the task of hosting clinical trials in order to take advantage of their substantial patient population, developing markets now provide a wide range of highly qualified people that can support the entire clinical trial process programming, for example. In addition to data processing, scientific research, biostatistics, and regulatory operations were soon added to the list of activities that were outsourced.

Clinical trials conducted on-site have been disrupted globally as a result of the COVID-19 epidemic. During this time, there was a major overhaul of the healthcare sector. As a response, regulatory bodies all over the world have launched a range of initiatives targeted at accelerating clinical trials in order to find novel remedies.

Positive growth in demand for outsourced clinical trials was influenced by COVID-19. Numerous sectors, notably the healthcare sector, witnessed major transformation, and during COVID-19, small and medium-sized biotech enterprises were on the edge of closing permanently.

Clinical Trials Outsourcing Market Report Highlights

  • Lead identification and candidate optimization category accounted for the majority of the worldwide outsourcing market for clinical trial in 2021. This segment is important because of the increased efficiency and related economies of scale. It is regarded as the most significant workflow at this point in the clinical trial procedure.
  • In 2021, the respiratory system market accounted for a major share. The rising prevalence of respiratory diseases such bronchitis, TB, along with the rise in drug resistance, have had an effect on the segment’s growth.
  • It was estimated that in 2021, pharmaceutical and biotechnology firms’ collaboration with CRO partners will generate a significant revenue. It is to discover more practical solutions to escalating development costs and complexity in a demanding regulatory and reimbursement environment.
  • North America is the industry leader in clinical trials outsourcing globally, accounting for a significant revenue share. This is primarily due to vendors available for clinical trials and the massive influx of investments in clinical trials.
  • The global market is extremely competitive due to the presence of prominent market players with a global presence, such as EVOTEC, Laboratory Corporation of America Holdings, Genscript, IQVIA, ICON, LabCorp Drug Development, Paraxel, LLC, Charles River, Wuxi apptec, and Merck & Co.
Polaris Market Research has segmented the clinical trials outsourcing market report based on workflow, therapeutic area, end-use, and region:

Clinical Trials Outsourcing, Workflow Outlook (Revenue – USD Billion, 2018 – 2030)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
Clinical Trials Outsourcing, Therapeutics area Outlook (Revenue – USD Billion, 2018 – 2030)
  • Respiratory System
  • Pain and Anaesthesia
  • Oncology
  • Ophthalmology
  • Haematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
Clinical Trials Outsourcing, End-Use Outlook (Revenue – USD Billion, 2018 – 2030)
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Others
Clinical Trials Outsourcing, Regional Outlook (Revenue – USD Billion, 2018 – 2030)
  • North America
  • U.S
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Clinical Trials Outsourcing Market Insights
4.1. Clinical Trials Outsourcing – Industry Snapshot
4.2. Clinical Trials Outsourcing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing number of clinical trials
4.2.1.2. Rising prevalence of orphan and rare diseases
4.2.2. Restraints and Challenges
4.2.2.1. Rising demand for specialized testing services among end users
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Clinical Trials Outsourcing Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Clinical Trials Outsourcing Market, by Workflow
5.1. Key Findings
5.2. Introduction
5.2.1. Global Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
5.3. Target Identification & Screening
5.3.1. Global Clinical Trials Outsourcing Market, by Target Identification & Screening, by Region, 2018 - 2030 (USD Billion)
5.4. Target Validation & Functional Informatics
5.4.1. Global Clinical Trials Outsourcing Market, by Target Validation & Functional Informatics, by Region, 2018 - 2030 (USD Billion)
5.5. Lead Identification & Candidate Optimization
5.5.1. Global Clinical Trials Outsourcing Market, by Lead Identification & Candidate Optimization, by Region, 2018 - 2030 (USD Billion)
5.6. Preclinical Development
5.6.1. Global Clinical Trials Outsourcing Market, by Preclinical Development, by Region, 2018 - 2030 (USD Billion)
5.7. Others
5.7.1. Global Other Clinical Trials Outsourcing Market, by Region, 2018 - 2030 (USD Billion)
6. Global Clinical Trials Outsourcing Market, by Therapeutics Area
6.1. Key Findings
6.2. Introduction
6.2.1. Global Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
6.3. Respiratory System
6.3.1. Global Clinical Trials Outsourcing Market, by Respiratory System, by Region, 2018 - 2030 (USD Billion)
6.4. Pain and Anaesthesia
6.4.1. Global Clinical Trials Outsourcing Market, by Pain and Anaesthesia, by Region, 2018 - 2030 (USD Billion)
6.5. Oncology
6.5.1. Global Clinical Trials Outsourcing Market, by Oncology, by Region, 2018 - 2030 (USD Billion)
6.6. Ophthalmology
6.6.1. Global Clinical Trials Outsourcing Market, by Ophthalmology, by Region, 2018 - 2030 (USD Billion)
6.7. Haematology
6.7.1. Global Clinical Trials Outsourcing Market, by Haematology, by Region, 2018 - 2030 (USD Billion)
6.8. Cardiovascular
6.8.1. Global Clinical Trials Outsourcing Market, by Cardiovascular, by Region, 2018 - 2030 (USD Billion)
6.9. Endocrine
6.9.1. Global Clinical Trials Outsourcing Market, by Endocrine, by Region, 2018 - 2030 (USD Billion)
6.10. Gastrointestinal
6.10.1. Global Clinical Trials Outsourcing Market, by Gastrointestinal, by Region, 2018 - 2030 (USD Billion)
6.11. Immunomodulation
6.11.1. Global Clinical Trials Outsourcing Market, by Immunomodulation, by Region, 2018 - 2030 (USD Billion)
6.12. Anti-infective
6.12.1. Global Clinical Trials Outsourcing Market, by Anti-infective, by Region, 2018 - 2030 (USD Billion)
6.13. Central Nervous System
6.13.1. Global Clinical Trials Outsourcing Market, by Central Nervous System, by Region, 2018 - 2030 (USD Billion)
6.14. Dermatology
6.14.1. Global Clinical Trials Outsourcing Market, by Dermatology, by Region, 2018 - 2030 (USD Billion)
6.15. Genitourinary System
6.15.1. Global Clinical Trials Outsourcing Market, by Genitourinary System, by Region, 2018 - 2030 (USD Billion)
7. Global Clinical Trials Outsourcing Market, by End-Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Global Clinical Trials Outsourcing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2018 - 2030 (USD Billion)
7.4. Academic Institutes
7.4.1. Global Clinical Trials Outsourcing Market, by Academic Institutes, by Region, 2018 - 2030 (USD Billion)
7.5. Others
7.5.1. Global Other Clinical Trials Outsourcing Market, by Region, 2018 - 2030 (USD Billion)
8. Global Clinical Trials Outsourcing Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Clinical Trials Outsourcing Market Assessment, By Geography, 2018 - 2030 (USD Billion)
8.3. Clinical Trials Outsourcing Market – North America
8.3.1. North America: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.3.2. North America: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.3.3. North America: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.3.4. Clinical Trials Outsourcing Market – U.S.
8.3.4.1. U.S.: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.3.4.2. U.S.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.3.4.3. U.S.: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.3.5. Clinical Trials Outsourcing Market – Canada
8.3.5.1. Canada: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.3.5.2. Canada.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.3.5.3. Canada: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4. Clinical Trials Outsourcing Market – Europe
8.4.1. Europe: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.2. Europe.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.3. Europe: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4.4. Clinical Trials Outsourcing Market – UK
8.4.4.1. UK: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.4.2. UK.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.4.3. UK: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4.5. Clinical Trials Outsourcing Market – France
8.4.5.1. France: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.5.2. France.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.5.3. France: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4.6. Clinical Trials Outsourcing Market – Germany
8.4.6.1. Germany: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.6.2. Germany.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.6.3. Germany: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4.7. Clinical Trials Outsourcing Market – Italy
8.4.7.1. Italy: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.7.2. Italy.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.7.3. Italy: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4.8. Clinical Trials Outsourcing Market – Spain
8.4.8.1. Spain: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.8.2. Spain.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.8.3. Spain: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4.9. Clinical Trials Outsourcing Market – Netherlands
8.4.9.1. Netherlands: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.9.2. Netherlands.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.9.3. Netherlands: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.4.10. Clinical Trials Outsourcing Market – Russia
8.4.10.1. Russia: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.4.10.2. Russia.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.10.3. Russia: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.5. Clinical Trials Outsourcing Market – Asia Pacific
8.5.1. Asia Pacific: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.5.2. Asia Pacific.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.3. Asia Pacific: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.5.4. Clinical Trials Outsourcing Market – China
8.5.4.1. China: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.5.4.2. China.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.4.3. China: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.5.5. Clinical Trials Outsourcing Market – India
8.5.5.1. India: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.5.5.2. India.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.5.3. India: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.5.6. Clinical Trials Outsourcing Market – Malaysia
8.5.6.1. Malaysia: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.5.6.2. Malaysia.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.6.3. Malaysia: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.5.7. Clinical Trials Outsourcing Market – Japan
8.5.7.1. Japan: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.5.7.2. Japan.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.7.3. Japan: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.5.8. Clinical Trials Outsourcing Market – Indonesia
8.5.8.1. Indonesia: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.5.8.2. Indonesia.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.8.3. Indonesia: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.5.9. Clinical Trials Outsourcing Market – South Korea
8.5.9.1. South Korea: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.5.9.2. South Korea.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.9.3. South Korea: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.6. Clinical Trials Outsourcing Market – Middle East & Africa
8.6.1. Middle East & Africa: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.6.2. Middle East & Africa.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.3. Middle East & Africa: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.6.4. Clinical Trials Outsourcing Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.6.4.2. Saudi Arabia.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.4.3. Saudi Arabia: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.6.5. Clinical Trials Outsourcing Market – UAE
8.6.5.1. UAE: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.6.5.2. UAE.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.5.3. UAE: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.6.6. Clinical Trials Outsourcing Market – Israel
8.6.6.1. Israel: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.6.6.2. Israel.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.6.3. Israel: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.6.7. Clinical Trials Outsourcing Market – South Africa
8.6.7.1. South Africa: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.6.7.2. South Africa.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.7.3. South Africa: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.7. Clinical Trials Outsourcing Market – Latin America
8.7.1. Latin America: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.7.2. Latin America.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.3. Latin America: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.7.4. Clinical Trials Outsourcing Market – Mexico
8.7.4.1. Mexico: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.7.4.2. Mexico.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.4.3. Mexico: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.7.5. Clinical Trials Outsourcing Market – Brazil
8.7.5.1. Brazil: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.7.5.2. Brazil.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.5.3. Brazil: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
8.7.6. Clinical Trials Outsourcing Market – Argentina
8.7.6.1. Argentina: Clinical Trials Outsourcing Market, by Workflow, 2018 - 2030 (USD Billion)
8.7.6.2. Argentina.: Clinical Trials Outsourcing Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.6.3. Argentina: Clinical Trials Outsourcing Market, by Therapeutics Area, 2018 - 2030 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Albany Molecular Research
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. EVOTEC
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Laboratory Corporation of America
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Genscript
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. IQVIA
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. ICON
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. LabCorp Drug Development
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Paraxel
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Charles River
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Wuxi Apptec
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Merck
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Thermo Fisher Scientific
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Dalton Pharma
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. Oncodesign
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. Jubilant Biosys
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development
10.16. Discoverx
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Recent Development
10.17. QIAGEN
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Recent Development
10.18. Eurofins
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. Product Benchmarking
10.18.4. Recent Development
10.19. Syngeneic International
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. Product Benchmarking
10.19.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings